Vaksin COVID-19: Malaysia lulus penggunaan kecemasan Sinopharm, Johnson & Johnson

KUALA LUMPUR: Pihak Berkuasa Kawalan Dadah (PBKD) meluluskan penggunaan secara kecemasan produk vaksin COVID-19 Sinopharm dan Johnson & Johnson, pada Jumaat.

Menurut Ketua Pengarah Kesihatan, Tan Sri Dr Noor Hisham Abdullah, kelulusan pendaftaran bersyarat ini memerlukan maklumat kualiti, keselamatan dan keberkesanan produk vaksin tersebut dipantau dan dinilai berdasarkan data-data terkini dari semasa ke semasa.

"Ini bagi memastikan perbandingan manfaat-risiko (benefit over risk) bagi produk-produk vaksin tersebut kekal positif.

"KKM akan sentiasa mempertingkatkan tahap kesihatan awam dalam memerangi wabak COVID-19 melalui perolehan bekalan vaksin yang telah dinilai daripada aspek kualiti, keselamatan dan keberkesanan oleh Bahagian Regulatori Farmasi Negara (NPRA) dan diluluskan oleh PBKD.

"Kelulusan tersebut diberikan selepas Mesyuarat PBKD Kali Ke-361 Berkenaan Pendaftaran Vaksin COVID-19," katanya dalam satu kenyataan, pada Jumaat.

Mengulas lanjut, Dr Noor Hisham berkata, Kerajaan juga komited untuk memastikan penduduk dewasa Malaysia mencapai imuniti kelompok (herd immunity) selaras dengan sasaran Program Imunisasi COVID-19 Kebangsaan (PICK).

Malaysia telah meluluskan beberapa jenis vaksin COVID-19 secara kecemasan, antaranya AstraZeneca, Pfizer-BioNTech, Sinovac, CanSino dan terbaharu Sinopharm serta Johnson & Johnson.

AWANI 7:45 [7/11/2024] – Siasatan kerugian FashionValet | Sanusi mohon maaf secara terbuka | Tidak dibenarkan ganggu mangsa | SOP baharu soket elektrik bas ekspres

Laporan berita padat dan ringkas #AWANI745 bersama Irfan Faruqi

Tumpuan #AWANI745 malam ini:

- Siasatan FashionValet diteruskan, apa nasib Vivy dan suami?
- Tinjauan dapati rakyat optimis hala tuju negara, rasuah kekal kebimbangan
- Sejak 2020, lebih 3,000 penjawat awam muflis, apa jadi punca?
- China ucap tahniah kemenangan Trump, ajak kerjasama demi sejagat

Saksikan #AWANI745 di saluran 501 Astro AWANI, Astro AWANI apps dan astroawani.com/live-tv

Consider This: Social Work Profession Bill (Part 1) — The Cost of Delay

The long-awaited Social Work Profession Bill, aimed at finally professionalising this sector through mandatory licensing and standards, was set to be tabled this year in Dewan Rakyat but tabling has been delayed. What does it mean for a country when its social support workforce is left unprotected and unregulated? And who bears the real cost of these delays? On this episode of #ConsiderThis Melisa Idris speaks with Dr Teoh Ai Hua, President of Malaysian Association of Social Workers, which has championed professional social work for five decades now and actively provides training for social workers in government and civil society sectors.

Consider This: Social Work Profession Bill (Part 2) — The Cost of Delay

The long-awaited Social Work Profession Bill, aimed at finally professionalising this sector through mandatory licensing and standards, was set to be tabled this year in Dewan Rakyat but tabling has been delayed. What does it mean for a country when its social support workforce is left unprotected and unregulated? And who bears the real cost of these delays? On this episode of #ConsiderThis Melisa Idris speaks with Dato’ Dr Amar-Singh HSS, consultant paediatrician and a child and disability activist.